|
drug_name
|
event_name
|
drug_id
|
event_id
|
|
butalbital
|
Dysphagia
|
1139699
|
31317
|
## Chronograph ##

## Table of sex and age##
|
|
Target drug + event
|
n
|
Percentage
|
|
Target drug
|
n
|
Percentage
|
|
Comp. drugs with event
|
n
|
Percentage
|
|
Comp. drugs
|
n
|
Percentage
|
|
|
Total
|
114
|
100
|
|
Total
|
1000
|
100
|
|
Total
|
881
|
100
|
|
Total
|
1000
|
100
|
|
Sex
|
gender = FEMALE
|
67
|
59
|
Sex
|
gender = FEMALE
|
583
|
58
|
Sex
|
gender = FEMALE
|
497
|
56
|
Sex
|
gender = FEMALE
|
546
|
55
|
|
|
gender = MALE
|
47
|
41
|
|
gender = MALE
|
417
|
42
|
|
gender = MALE
|
384
|
44
|
|
gender = MALE
|
454
|
45
|
|
Age
|
(0,20]
|
0
|
0
|
Age
|
(0,20]
|
0
|
0
|
Age
|
(0,20]
|
0
|
0
|
Age
|
(0,20]
|
0
|
0
|
|
|
(20,30]
|
2
|
2
|
|
(20,30]
|
3
|
0
|
|
(20,30]
|
6
|
1
|
|
(20,30]
|
8
|
1
|
|
|
(30,40]
|
5
|
4
|
|
(30,40]
|
16
|
2
|
|
(30,40]
|
20
|
2
|
|
(30,40]
|
13
|
1
|
|
|
(40,50]
|
4
|
4
|
|
(40,50]
|
60
|
6
|
|
(40,50]
|
34
|
4
|
|
(40,50]
|
42
|
4
|
|
|
(50,60]
|
10
|
9
|
|
(50,60]
|
75
|
8
|
|
(50,60]
|
49
|
6
|
|
(50,60]
|
56
|
6
|
|
|
(60,70]
|
27
|
24
|
|
(60,70]
|
225
|
22
|
|
(60,70]
|
187
|
21
|
|
(60,70]
|
231
|
23
|
|
|
(70,80]
|
31
|
27
|
|
(70,80]
|
332
|
33
|
|
(70,80]
|
334
|
38
|
|
(70,80]
|
385
|
38
|
|
|
(80,90]
|
23
|
20
|
|
(80,90]
|
231
|
23
|
|
(80,90]
|
192
|
22
|
|
(80,90]
|
220
|
22
|
|
|
(90,110]
|
12
|
11
|
|
(90,110]
|
58
|
6
|
|
(90,110]
|
59
|
7
|
|
(90,110]
|
45
|
4
|
|
|
Median
|
72
|
IQR=(67, 82)
|
|
Median
|
73
|
IQR=(67, 82)
|
|
Median
|
74
|
IQR=(68, 82)
|
|
Median
|
74
|
IQR=(68, 81)
|
## Gender plot ##
## Below: Percentages and Standardized differences for preexisting conditions and comedications, using a 180 day lookback window from drug start. ('OHDSI Table1'). Standardized difference ('Std Diff') is difference in means divided by standard deviation. ##
## Below: Top preexisting comedications, using a 180 day lookback window from drug start, counts and percentages. Covariates are 'raw', i.e. not grouped as in 'OHDSI table1' above. ##
## Below: Top preexisting conditions, using a 180 day lookback window from drug start, counts and percentages. Covariates are 'raw', i.e. not grouped as in 'OHDSI table1' above. ##